Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment
(NYSE: BHVN) Delayed: 15.50 +1.93 (14.22%)
Previous Close $13.57    52 Week High $ 
Open $14.07    52 Week Low $ 
Day High $15.67    P/E N/A 
Day Low $14.07    EPS $ 
Volume 5,772,467       

(NASDAQ: PRTG) Delayed: 6.81 --0 (-0%)
Previous Close $6.81    52 Week High $ 
Open $6.81    52 Week Low $ 
Day High $6.81    P/E N/A 
Day Low $6.81    EPS $ 
Volume 104,029